Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

Effects of Atorvastatin of Early Recurrent Ischemic Events in Acute Coronary Syndromes: A Randomized Controlled Trial

Article Abstract:

The cholesterol-lowering drug atorvastatin may reduce the risk of recurring ischemia in the first few months after a heart attack or unstable angina, according to a study of 3,086 patients. Ischemia occurs when part of the body does not receive enough blood.

Author: Chaitman, Bernard R., Waters, David, Schwartz, Gregory G., Olsson, Anders G., Ezekowitz, Michael D., Ganz, Peter, Oliver, Michael F., Zeiher, Andreas, Leslie, Sally, Hell, Richard
Publisher: American Medical Association
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 2001
Evaluation

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA

Lipid-Lowering Therapy in Acute Coronary Syndromes

Article Abstract:

All patients who are hospitalized for a heart attack or unstable angina should receive a drug to lower their cholesterol level. A study published in 2001 showed that this treatment reduced the risk of recurring symptoms in the following months.

Author: Sacks, Frank M.
Publisher: American Medical Association
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 2001
Health aspects, Editorial

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA

High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction

Article Abstract:

The effects of two strategies of lipid lowering on the risk of cardiovascular disease among patients with a previous myocardial infarction (MI) are compared. Results reveal that patients with MI might benefit from intensive lowering of low-density lipoprotein cholesterol (LDL-C) without an increase in noncardiovascular mortality or other serious adverse reactions.

Author: Olsson, Anders G., Tikkanen, Matti J., Larsen, Mogens Lytken, Holme, Ingar, Kastelein, John J.P., Pedersen, Terje R., Szarek, Michael, Tsai, John, Faergemann, Ole, Lindahl, Christina, Bendiksen, Fredrik S.
Publisher: American Medical Association
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 2005
United States, Comparative analysis, Dosage and administration, Simvastatin, Atorvastatin

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Prevention, Unstable angina, Drug therapy, Heart attack, Ischemia, Anticholesteremic agents
Similar abstracts:
  • Abstracts: Impact of Disseminating Quality Improvement Programs for Depression in Managed Primary Care: A Randomized Controlled Trial
  • Abstracts: Effectiveness and Cost-Benefit of Influenza Vaccination of Healthy Working Adults: A Randomized Controlled Trial
  • Abstracts: Evaluation of prolonged antithrombotic pretreatment ("cooling-off" strategy) before intervention in patients with unstable coronary syndromes: a randomized controlled trial
  • Abstracts: Leukocyte-Reduced Red Blood Cell Transfusions in Patients With Anemia and Human Immunodeficiency Virus Infection: A Randomized Controlled Trial
  • Abstracts: The influence of fish, meat and polyunsaturated fat intakes on platelet phospholipid polyunsaturated fatty acids in male Melbourne Chinese and Caucasian
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.